Marrone Bio Innovations Inc. (MBII)

Business: Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition.

IPO Date: 02-Aug-2013

CEO & Director: Mr. Kevin R. Helash

Founder, Advisor & Non-Employee Director: Dr. Pamela G. Marrone Ph.D.

Listing: NASDAQ: MBII

Country: United States

Headquarters: Raleigh, NC

Website: https://www.marronebio.com

Market cap: $193.32 Mln

Revenue (TTM): $33.65 Mln

Earnings (TTM): $-18.61 Mln

Cash: $9.36 Mln

Total Debt: $35.46 Mln

Insider's Holding: 1.98%

Liquidity: Low

52 Week range: $0.55 - 1.70

Shares outstanding: 182,336,992

10 Years Aggregate:

• CFO: $-230.40 Mln
• EBITDA: $-226.99 Mln
• Net Profit: $-290.05 Mln